Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.

Published in: ACS medicinal chemistry letters (2023)

Provided herein are novel tricyclic compounds as KRAS inhibitors, pharmaceutical compositions, use of such compounds in treating cancer and processes for preparing such compounds.

Keyphrases

papillary thyroid
squamous cell
squamous cell carcinoma
lymph node metastasis
wild type
young adults